Sarda Proteins: Independent Directors Endorse Open Offer

17,30,400 Equity Shares; 19.28% Stake; ₹115.00 per share

Reader Takeaway: Independent directors deem offer fair; shareholders have an exit option at a set price.

What just happened

The Committee of Independent Directors (IDC) for Sarda Proteins Limited has reviewed and recommended the open offer made by Onix Renewable Limited. The IDC, comprising Mr. Suresh Rajeswar (Chairman), Mr. Vijay Kumar Gupta, and Mr. Vinit Parasram, has concluded that the offer is fair and reasonable for public shareholders.

Onix Renewable Limited is offering to acquire 17,30,400 equity shares, representing 19.28% of the company's emerging voting share capital, at a price of ₹115.00 per share.

Why this matters

This endorsement from the independent directors provides a level of institutional validation for the offer price. It signals to shareholders that the company's independent oversight believes the terms are equitable. The open offer presents an opportunity for existing shareholders to exit their investment at a predetermined price.

The backstory

The open offer is being conducted by Onix Renewable Limited and its Persons Acting in Concert (PACs) in accordance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The offer price of ₹115.00 per share has been determined based on the criteria stipulated in these regulations.

What changes now

For shareholders, the key change is the clear recommendation from the IDC. This may influence their decision on whether to participate in the open offer. The revised timeline provides clarity on when they can act.

Risks to watch

While the IDC has deemed the offer fair, shareholders must consider the prevailing market price of Sarda Proteins' shares. If the market price is significantly higher than ₹115.00, participating in the open offer might not be attractive. Conversely, if the market price is lower, the offer provides a guaranteed exit at ₹115.00.

Peer comparison

Information on typical open offer pricing relative to market prices for similar companies in the edible oil and related products sector is not provided in the filing.

Context metrics (time-bound)

The tendering period for the open offer is set to expire on Monday, June 22, 2026. The last date for communicating acceptance and payment is Tuesday, July 07, 2026.

What to track next

Investors should monitor the number of shares tendered during the open offer period. Tracking the company's market performance relative to the offer price will also be crucial for shareholders deciding whether to participate.